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hospitalization and outpatient hospital visit were assessed using
Cox-proportional hazard models. Counts of ofﬁce visits were
assessed using negative binomial regression models. RESULTS:
Elders with a claim for depression had a higher frequency of
inpatient hospitalizations (52.4%) and emergency department
visits (29.7%) than elders without a depression claim (36.4%
and 19.1%). Elders with a depression claim were admitted to the
hospital 51% sooner (95% CI = 1.31, 1.76), visited an emer-
gency department 56% sooner (95% CI = 1.29, 1.90), and had
an outpatient hospital visit 19% sooner (95% CI = 1.03, 1.38)
than elders without a depression claim. A depression claim had
no effect on the number of physician ofﬁce visits. Antidepressant
use by elders with a depression claim was not signiﬁcantly asso-
ciated with health care utilization. CONCLUSION: Elders with
a claim for depression after a TCE use more acute health care
services and sooner than those without a depression claim.
Antidepressant use does not affect this relationship.
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OBJECTIVE: Upon implementation of Medicare Part D in 2006,
Medicaid and Medicare dual-eligibles were shifted to Part D for
their prescription drug coverage. This shift affected the utiliza-
tion and market share of medications under Medicaid. This study
focuses on statins which are widely prescribed. The objectives
were: 1) to describe the number of units dispensed, the number of
prescriptions, and total expenditures for statins in 2005 and
2006, nationally and for each state, and 2) to assess the shift
in market share for these drugs between 2005 and 2006.
METHODS: Summary claims data for 11 commonly prescribed
statins were obtained from the Centers for Medicare and Med-
icaid Services website for all US states for 2005 and 2006. Total
units of statins reimbursed, total number of prescriptions, total
reimbursement amount, and percent market share were calcu-
lated for each of the statins and for each of the 50 states.
RESULTS: The total units of statins reimbursed decreased from
573.5 million in 2005 to 201.0 million in 2006, as did the total
number of prescriptions (17.5 million in 2005 vs. 6.2 million in
2006), and the total reimbursement amount ($1.8 billion in 2005
vs. $0.66 billion in 2006). The percentage market share of
Lipitor® units decreased from 48.7% in 2005 to 42.8% in 2006.
Similar trends were observed for percentages of prescriptions and
reimbursement amounts. Zocor® also showed the same trend
while Vytorin® and generic statin use increased. State wise com-
parisons show variability among states with CA and NY having
the highest statin use. CONCLUSION: Overall, the ﬁndings of
the study indicate a substantial decrease in statin prescriptions
covered by Medicaid for the year 2006. This decrease in utiliza-
tion along with the shift to generic statins affects the rebates
received by Medicaid.
PCV86
PATTERNS OF DIURETIC USE IN MULTI-DRUG
ANTI-HYPERTENSIVE REGIMENS INTHE POST ALLHAT ERA
Parikh NM1, Singh H2,Ashton C3, Sharma M1,Yadav R1,Walder A4,
Johnson M5
1University of Houston, Houston,TX, USA, 2Michael E. DeBakey
Veterans Affairs Medical Center ; Baylor College of Medicine,
Houston,TX, USA, 3University of Alabama, Birmingham, AL, USA,
4Michael E. DeBakey Veterans Affairs Medical Center, Houston,TX,
USA, 5University of Houston; Michael E. DeBakey Veterans Affairs
Medical Center, Houston,TX, USA
OBJECTIVE: Our study goal was to determine if the proportion
of “diuretic eligible” patients receiving diuretics, including thi-
azides, for hypertension control in multi-drug antihypertensive
regimens has increased since the publication of ALLHAT and
JNC7. METHODS: We used an electronic medical records
repository of a tertiary care VA Medical Center to determine
medication use in 8286 non-diabetic hypertensives in March
2005. Patients selected did not have contraindications for thiaz-
ides (gout, heart failure, creatinine >=2 mg/dL) and were catego-
rized as receiving one, two, three, or four or more drugs. Diuretic
use overall, for the elderly (age60 years) and African-American
subgroups was compared to March 2001 levels. RESULTS: Rates
of any diuretic use were 27.6%, 56.7%, 78.2% and 90.5% in
people on single, two, three and four or more drugs respectively.
Thiazide use rates were 26.7%, 52.6%, 69.7%, and 77.8% in
those groups, respectively. Comparable rates of thiazide diuretics
utilization from 2001 were 11.6%, 39%, 59%, and 72.5%,
respectively (p < 0.05 for all comparisons). The proportion of
African-American patients on 2, 3, or 4 or more drugs was
67.5%, 84.6% and 91.6% respectively (p < 0.05 for all compari-
sons except 4 or more drugs; p = 0.102). Overall, 49% of the
elderly received diuretics: 22.6% on monotherapy (p < 0.05),
and 49.6%, 75.2% and 91.6% on 2, 3, or 4 or more drugs
(p > 0.05). CONCLUSION: Use of thiazides to treat multidrug
hypertension has increased since release of JNC-7 and ALLHAT,
indicating evidence-based provision of care in the VA. However,
there is still room for improvement and need for additional study
of factors affecting thiazide use in hypertensive patients,
especially the elderly.
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OBJECTIVE: To determine the rate of off-label prescribing of
statins for patients diagnosed with hypertension and/or diabetes
and to identify the patient and physician characteristics affecting
the prescribing of statins. METHODS: Data from the National
Ambulatory Medical Care Survey (NAMCS) for the year 2005
was used. Hypertension and diabetes visits were identiﬁed based
on the ICD-9-CM diagnoses code, reason-for-visit codes, and an
afﬁrmative answer to a question asking whether the patient is
currently suffering from hypertension/diabetes. Statin visits were
identiﬁed using the NAMCS generic drug codes. “On-label”
statin visits deﬁned as visits having ICD-9-CM diagnoses code,
reason-for-visit code for hyperlipidemia, Acute Myocardial Inf-
arction, Ischemic Heart Disease, Angina, & Atherosclerosis,
a CPT-4 code for revascularization, or a lipid lab test were
excluded. Multivariate logistic regression models were applied
using Stata 9 to take into account the complex survey design.
RESULTS: In 2005, 23.1 million diabetes visits (95% CI = 18.3–
28.0 million), and 50.1 million hypertension visits (95%
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CI = 40.7–59.5 million), resulted in a statin prescription repre-
senting 24%, and 22%, of the total visits for the two conditions
respectively. Patients aged 41–60 years (OR = 3.49, 95%
CI = 1.43–8.47) or 61–80 years (OR = 3.98, 95% CI = 1.40–
11.31), or those from metropolitan areas (OR: 2.23, 95% CI:
1.11–4.48) were more likely to receive a statin prescription
compared to the respective baseline groups. Whereas residing in
the northeast (OR = 0.44, 95% CI = 0.26–0.75) or midwest
(OR = 0.40, 95% CI = 0.21–0.77) regions or being black
(OR = 0.50, 95% CI = 0.29–0.87) predict signiﬁcantly lower
odds of receiving statin prescription compared with the south
region and nonhispanic whites or other race groups. CONCLU-
SION: As expected, age was the most important factor determin-
ing the prescribing of statins in hypertension and/or diabetes. It is
not clear if these rates of statin prescribing reﬂect aggressive
off-label prescribing or undercoding of on-label diagnoses. Data
on more years needs to be analyzed to conﬁrm the ﬁndings.
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OBJECTIVE: To investigate the trend of ambulatory calcium
channel blockers (CCBs) utilization in Taiwan according to the
national health insurance claims over an eight-year period.
Special attention would be paid to the extent and situations of
prescribing ﬁrst-line (short-acting) CCBs on a PRN (pro re nata)
order. METHODS: The visit-based sampling claims datasets
of ambulatory care visits from 1997 to 2004, offered by the
National Health Insurance Research Database, were analyzed.
The datasets represented 0.2% of total ambulatory care visits
within the National Health Insurance in Taiwan. The utilization
of CCBs was stratiﬁed by ingredient and formulation, and the
prescriptions of CCBs on a PRN order by the patient’s age, the
prescribing physician’s specialty, and the setting of health care
facility. RESULTS: During the study period, the CCBs had
remained as the most popular antihypertensive agents in Taiwan.
The number of deﬁned daily doses (DDDs) of all CCBs per 1000
inhabitants per day increased from 15.3 in 1997 to 36.4 in 2004.
The growth of CCBs was attributed to second- and third-
generation CCBs, especially amlodipine. While the ﬁrst-line
CCBs, mainly short-acting nifedipine, became less popular with
time (from 6.0 DDDs per 1000 inhabitants per day in 1997 to
3.5 in 2004), their PRN use did not have a diminishing trend. In
2004, the short-acting nifedipine on a PRN order still existed in
1.5% of prescriptions containing antihypertensive agents and
3.4% of prescriptions containing CCBs. More than one half of
these PRN orders were prescribed by the internists and to the
elderly patients; almost four-ﬁfths of these PRN orders were
prescribed during normal consultations. CONCLUSION: The
physicians in Taiwan still had the habit of prescribing short-
acting CCBs both on regular use and on PRN use. The reason
for such practices and the impact on patients’ health deserve
attention.
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OBJECTIVE: This study examined associations between pre and
post stroke statin use with health care costs among elderly stroke
survivors enrolled in a Medicare Health Maintenance Organiza-
tion (HMO). METHODS: This was a retrospective analysis of
Medicare HMO in the southeastern region of United States.
Stroke survivors were identiﬁed using primary inpatient dis-
charge codes of 434.xx or 436.xx during the ‘enrollment period’
from January 1, 2000 to December 31, 2002. Patients were
required to have at least 2 prescription ﬁlls for HMG-CoA reduc-
tase inhibitors (statin) and continuous eligibility to the HMO
beneﬁts during index period. Medication adherence was calcu-
lated using prescription reﬁlls. Multivariate log-linear regression
analyses were used to determine predictors of health care costs.
RESULTS: A total 181 stroke patients with mean age of 74.3
years (SD = 7.6) and over 60% were studied. Over 55.2%
patients were on atorvastatin, followed by simvastatin with
24.3%. The average medication possession ratio for statins
was 49.6%. Patients reported poor health status and signiﬁcant
comorbidity. In multivariate log-linear regression analyses
factors, we found that statin use in the year prior to stroke (27%
of the patients) was signiﬁcantly associated with decreased health
care costs (p < 0.05). The only other factor signiﬁcantly associ-
ated with increased health care costs in the post-stroke year
was increased comorbidity severity (p < 0.001). CONCLUSION:
Statin use in elderly HMO enrolled elderly patients in the pre-
stroke period was signiﬁcantly associated with signiﬁcant reduc-
tions in health care utilization and costs in the post-stroke year.
Prophylactic statin use in elderly patients at risk for stroke may
be warranted to decrease post-stroke morbidity resulting in sig-
niﬁcant health care costs.
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OBJECTIVE: To estimate and compare annual medical expen-
ditures and utilization attributed to hypertension in men and
women of the U.S. And to investigate predisposing, enabling and
need predictors of gender differences in hypertension attribut-
able medical expenditures and utilization. METHODS: Proce-
dural equity was assessed by applying the theoretical framework
developed by Aday et.al. We used the 2001–2004 Medical
Expenditure Panel Survey (MEPS) and regression models to esti-
mate medical expenditures and utilization. A cross-sectional
study design was used and unit of analysis was person-year. The
interaction between hypertension and gender was used to study
gender differences. We estimated incremental health care utiliza-
tions attributed to hypertension as difference in utilization and
expenditures between hypertensive and non-hypertensive indi-
viduals. Percentage changes in total and attributable utilization
and expenditures of hypertensive men relative to hypertensive
women were also estimated. RESULTS: Weighted mean total
medical expenditure for hypertensive women and men was
$5512 and $5266 respectively. However, total expenditure
attributable to hypertension for hypertensive women and men
was $3272 and $3910 respectively. Therefore, hypertensive men
had 19.5% more attributable expenditures relative to hyperten-
sive women. Hypertensive women had signiﬁcantly more ofﬁce
visits, prescription drug and outpatient visits. However, similar
to total expenditure, hypertensive men had 27.3% more ofﬁce
visits, 2.9% more prescription drug, and 10.9% more outpatient
visits that is attributable to hypertension than hypertensive
women. CONCLUSION: Gender remained signiﬁcant predictor
of resource use even after controlling for predisposing, enabling
and need factors. Hypertensive women had more utilization and
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